Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Cash Flow Statement
Cash Flow Statement
Centessa Pharmaceuticals PLC
| Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||||
| Net Income |
(11)
|
(247)
|
(286)
|
(324)
|
(381)
|
(196)
|
(219)
|
(234)
|
(216)
|
(212)
|
(173)
|
(157)
|
(151)
|
(138)
|
(157)
|
(161)
|
(236)
|
(224)
|
(230)
|
(243)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Stock-Based Compensation |
0
|
3
|
6
|
10
|
15
|
18
|
20
|
23
|
25
|
26
|
28
|
29
|
29
|
30
|
32
|
33
|
34
|
33
|
33
|
31
|
|
| Other Non-Cash Items |
1
|
224
|
238
|
245
|
252
|
35
|
19
|
20
|
21
|
23
|
8
|
6
|
33
|
35
|
59
|
62
|
68
|
65
|
65
|
64
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
4
|
3
|
3
|
3
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
1
|
3
|
5
|
7
|
7
|
8
|
9
|
10
|
10
|
10
|
10
|
10
|
10
|
9
|
9
|
9
|
|
| Change in Working Capital |
(1)
|
4
|
(4)
|
(4)
|
(6)
|
(12)
|
2
|
9
|
(6)
|
(9)
|
(19)
|
(30)
|
(44)
|
(47)
|
(49)
|
(31)
|
24
|
(4)
|
20
|
(3)
|
|
| Cash from Operating Activities |
(11)
N/A
|
(20)
-84%
|
(52)
-164%
|
(82)
-59%
|
(135)
-65%
|
(173)
-28%
|
(199)
-15%
|
(205)
-3%
|
(201)
+2%
|
(198)
+1%
|
(183)
+8%
|
(181)
+1%
|
(160)
+11%
|
(150)
+7%
|
(146)
+2%
|
(130)
+11%
|
(142)
-9%
|
(162)
-14%
|
(144)
+11%
|
(181)
-26%
|
|
| Investing Cash Flow | |||||||||||||||||||||
| Capital Expenditures |
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
|
| Other Items |
0
|
64
|
63
|
63
|
63
|
(0)
|
0
|
0
|
0
|
(86)
|
(157)
|
(108)
|
(127)
|
(24)
|
(8)
|
(12)
|
31
|
(208)
|
(192)
|
(175)
|
|
| Cash from Investing Activities |
0
N/A
|
64
N/A
|
63
0%
|
63
0%
|
63
0%
|
(1)
N/A
|
(1)
-16%
|
(1)
+5%
|
(1)
-69%
|
(87)
-9 258%
|
(158)
-81%
|
(109)
+31%
|
(127)
-16%
|
(24)
+81%
|
(9)
+64%
|
(12)
-40%
|
31
N/A
|
(208)
N/A
|
(192)
+8%
|
(175)
+9%
|
|
| Financing Cash Flow | |||||||||||||||||||||
| Net Issuance of Common Stock |
0
|
242
|
588
|
586
|
587
|
345
|
(1)
|
1
|
1
|
0
|
0
|
15
|
21
|
32
|
140
|
372
|
371
|
368
|
261
|
18
|
|
| Net Issuance of Debt |
1
|
0
|
0
|
1
|
74
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
|
| Other |
0
|
0
|
0
|
(0)
|
(0)
|
(1)
|
(1)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
(3)
|
(4)
|
(5)
|
(10)
|
(7)
|
(7)
|
|
| Cash from Financing Activities |
1
N/A
|
243
+17 786%
|
589
+142%
|
587
0%
|
660
+12%
|
418
-37%
|
73
-83%
|
75
+3%
|
0
-99%
|
0
-15%
|
0
-15%
|
15
+4 400%
|
21
+42%
|
32
+50%
|
137
+334%
|
368
+169%
|
365
-1%
|
357
-2%
|
253
-29%
|
11
-96%
|
|
| Change in Cash | |||||||||||||||||||||
| Effect of Foreign Exchange Rates |
(0)
|
1
|
4
|
4
|
2
|
2
|
(2)
|
(3)
|
(0)
|
1
|
1
|
2
|
1
|
0
|
(0)
|
(2)
|
1
|
(1)
|
(1)
|
1
|
|
| Net Change in Cash |
(9)
N/A
|
288
N/A
|
605
+110%
|
572
-5%
|
590
+3%
|
247
-58%
|
(129)
N/A
|
(134)
-4%
|
(201)
-50%
|
(284)
-41%
|
(339)
-19%
|
(273)
+19%
|
(266)
+3%
|
(142)
+47%
|
(18)
+87%
|
224
N/A
|
255
+14%
|
(13)
N/A
|
(83)
-535%
|
(345)
-316%
|
|
| Free Cash Flow | |||||||||||||||||||||
| Free Cash Flow |
(11)
N/A
|
(20)
-85%
|
(52)
-163%
|
(82)
-59%
|
(135)
-65%
|
(173)
-28%
|
(199)
-15%
|
(206)
-3%
|
(202)
+2%
|
(199)
+1%
|
(183)
+8%
|
(182)
+1%
|
(161)
+12%
|
(150)
+7%
|
(147)
+2%
|
(130)
+11%
|
(142)
-9%
|
(162)
-14%
|
(144)
+11%
|
(181)
-26%
|
|